10x Genomics, Inc.
TXG
주식 순위
#2210
Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012... Headquartered in Pleasanton, California, 10x Genomics, Inc. (founded in 2012 and known as 10X Technologies, Inc. until November 2014) is a prominent life science technology company. The firm specializes in creating and distributing sophisticated instrumentation, essential consumables, and software designed for in-depth analysis of biological systems. Its market presence extends globally, covering North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company's offerings feature Chromium and Chromium Connect instruments, supported by indispensable items such as microfluidic chips, slides, and reagents. A significant portion of their portfolio focuses on single-cell solutions, leveraging their Chromium platforms. These allow for precise measurement of gene activity at the individual cell level (single cell gene expression), detailed assessment of immune cell function and their targets (single cell immune profiling), exploration of DNA's physical organization and epigenetic modifications (single cell Assay for Transposase Accessible Chromatin - ATAC), and the concurrent quantification of both genetic activity and epigenetic programming across tens of thousands of cells in a single experiment (single cell multiome ATAC + gene expression). Additionally, 10x Genomics offers the Visium spatial gene expression solution, which maps gene activity patterns within specific tissue sections and can also facilitate co-detection of gene expression and proteins when paired with immunofluorescence. Their varied customer base includes academic, governmental, biopharmaceutical, and biotechnology organizations, among others.
주가
$70.28
마지막 동기화: 2026-10-19
시가총액
$9.16B
변동 (1일)
0.60%
변동 (1년)
434.84%
국가
US
거래 10x Genomics, Inc. (TXG)
카테고리
Healthcare
10x Genomics, Inc. (TXG)의 수익
Jun 2026 기준 수익 TTM: $-74.89M
10x Genomics, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익은 $-74.89M입니다. 2024년에 회사는 $-177.70M의 수익을 올렸으며 이는 2023년의 수익 $-248.76M과 증가입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
10x Genomics, Inc.의 수익 기록 (2017 ~ 2026)
연말 수익
| 연도 | 수익 | 변화 |
|---|---|---|
| 2026 (TTM) | $-74.89M | 87.66% |
| 2025 | $-39.91M | -77.54% |
| 2024 | $-177.70M | -28.57% |
| 2023 | $-248.76M | 53.58% |
| 2022 | $-161.97M | 201.54% |
| 2021 | $-53.72M | -89.95% |
| 2020 | $-534.48M | 1,622.28% |
| 2019 | $-31.03M | -72.39% |
| 2018 | $-112.40M | 499.74% |
| 2017 | $-18.74M | 0.00% |
유사 기업 또는 경쟁사의 수익
| 회사 | 수익 | 수익 차이 | 국가 |
|---|---|---|---|
| $2.04B | -2,828.00% |
US
|
|
| $266.26M | -455.53% |
AU
|
|
| $295.53M | -494.62% |
US
|
|
| $-259.89M | 247.03% |
US
|
|
| - | - |
US
|
